A phase I–II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer
Open Access
- 1 November 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 9 (11) , 1247-1249
- https://doi.org/10.1023/a:1008445123416
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1997
- Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.Journal of Clinical Oncology, 1996
- Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group.Journal of Clinical Oncology, 1996
- Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1995
- Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.Journal of Clinical Oncology, 1994
- Reporting results of cancer treatmentCancer, 1981